Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2025-12-24 @ 3:20 PM
NCT ID:
NCT03924492
Eligibility Criteria:
Inclusion Criteria:
1. Subject has signed an informed consent form prior to any study-specific procedures being performed
2. Subject is an ambulatory female at least 18 years of age
3. Subject agrees to adhere to the study requirements
4. Subject agrees not to be the primary caregiver of any dependents during the infusion
5. Subject must have a negative pregnancy test on Day 1 prior to the start of the ZULRESSO infusion
6. Subject has a current diagnosis of PPD, as assessed by the Investigator
Exclusion Criteria:
1. Subject has end stage renal disease
2. Subject has a known allergy to progesterone or allopregnanolone
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03924492
Study Brief:
Protocol Section:
NCT03924492